# Effect of Intravenous Acetadote on Incidence of Contrast Induced Nephropathy

> **NCT00939913** · PHASE4 · UNKNOWN · sponsor: **Ochsner Health System** · enrollment: 400 (estimated)

## Conditions studied

- Nephropathy

## Interventions

- **DRUG:** intravenous NAC
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00939913
- **Lead sponsor:** Ochsner Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-01
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2009-09-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00939913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00939913, "Effect of Intravenous Acetadote on Incidence of Contrast Induced Nephropathy". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00939913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*